Atamyo Therapeutics
Paris · Founded 2020
About Atamyo Therapeutics
Atamyo Therapeutics is focused on the development of a new generation of safe and effective gene therapies for neuromuscular diseases. The company was founded in 2020 by Stephane Degove and Isabelle Richard and its headquarters is located in Paris, France.
Company Facts
- Founded: 2020
- Legal name: Atamyo Therapeutics SAS
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Funding stage: Seed
- Last round: Seed (Jul 2024)
- Website: atamyo.com
- Phone: [email protected]
Social Profiles
Canonical: https://fsome.com/organization/atamyo-therapeutics-8240928 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.